Selection of restriction specificities of virus-specific cytotoxic T cells in the thymus: no evidence for a crucial role of antigen- presenting cells by unknown
Brief Det~nitive Report 
SELECTION  OF  RESTRICTION  SPECIFICITIES  OF 
VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS  IN  THE  THYMUS: 
NO  EVIDENCE  FOR  A  CRUCIAL  ROLE  OF 
ANTIGEN-PRESENTING  CELLS* 
BY  ROLF  M.  ZINKERNAGEL 
From the Institute for Pathology, University of Zurich,  Universitiitsspital, CH-8091 Ziirich, Switzerland 
Thymus-derived lymphocytes functionally express two specificities, one for major 
histocompatibility gene complex  (MHC)-coded self major  transplantation  antigens 
and one for foreign antigenic determinants. It is still experimentally unproven whether 
they express one or two receptor sites  (reviewed in  1-3). The restriction specificity of 
T  cells is influenced profoundly during their differentiation in the thymus (1, 2). It is 
not clear whether this process involves positive selection alone or in conjunction with 
suppressive mechanisms. It is probable that thymic selection represents only (a crucial) 
part of the differentiation  pathway and  that  post-thymic maturation  is  required  to 
amplify the selected T  cells (1,  3-5). 
Experiments with irradiation bone-marrow chimeras or thymus transplants  recon- 
stituting thymus- and T  cell-deprived mice have indicated  that  radioresistant  (900- 
1,200 rad)  cells in the thymus were crucially involved in determining the restriction 
specificity of T  cells  (1,  2).  Thymic epithelial  cells  (including thymic nurse  cells;  6) 
and  antigen-presenting  cells  have  been  envoked  to  fulfil  this  function.  Longo and 
Schwartz (7)  have confirmed that early after irradiation  thymic H-2 determined the 
restriction  specificity of chimeric T  cells.  In addition,  they presented  evidence  that 
antigen-presentingcells turn over slowly in the thymus; therefore, donor bone marrow- 
derived  antigen-presenting  cells  appear  only  a  few  weeks  after  irradiation  in  the 
thymus  and  only  then  are  capable  of selecting  maturing  H-2-restricted  antigen- 
specific proliferative T  cells  3-5  mo  after  irradiation,  but  according to  the  H-2  of 
antigen-presenting cells rather than  the  thymic H-2 type.  The study reported  here, 
which  uses  similar  and  additional  protocols,  indicates  that  bone  marrow-derived 
antigen-presenting cells are not crucially involved in thymic selection of virus-specific, 
MHC-restricted cytotoxic T  cells. 
Materials and Methods 
Chimeras and Experimental Procedures.  Irradiation bone marrow chimeras of F~ ---> P type were 
produced as published previously (1, 8). Parental recipient mice were irradiated with 850  950 
rad and  reconstituted with T  cell-depleted stem cells  1 d  later.  Such conventional chimeras 
were used  for further experiments at  ~16  20  wk after reconstitution.  Various experimental 
protocols were used to deplete established chimeras of mature T  cells:  (a) Mice were treated 
with cortisone acetate  (5 mg subcutaneously, Merck Sharp & Dohme, West  Point, PA) and 
rabbit anti-lymphocyte serum (ALS). The ALS had been prepared by injection of 108 CBA or 
C57BL/6 thymus cells  intravenously into rabbits  four times in weekly intervals;  the rabbits 
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TABLE 
Testing of Various Protocols  for T Cell Depletion In  Vivo 
Protocol 
Treatments on days 
-6  --4  -2  0  +2 
Anti vacci- 
Number of 
nia CTL- 
spleen cells 
response on 
on d6 in 
percent of  day 6  in 
percent of 
controls 
controls 
I  ALS  ALS  .... 100  ~30 
2  --  ALS  .... 130  ~50 
3  --  AL5  ALS  --  ~  100  ~30 
4  --  --  --  ALS  AI,S  ~100  ~20 
5  cortisone  ALS  ALS  --  --  ~5  <5 
6  ALS  ALS  cortisone  --  --  ~50  ~20 
7  cortisone  ALS  ALS +  cortisone  --  --  All animals died during vaccinia 
virus infection 
8  cortisone  .....  50  ~80 
9  --  --  co rt isone  --  --  100  ~  100 
I  0  tort isone  --  cortisone  --  --  ~ 70  ~  I (~ 
.....  100  100 
10 protocols were evaluated with respect to effectiveness of T  cell depletion (pratocols 5  and  7 were most efficient). 0.1  ml of a  rabbit anti 
(C57BL/6 or CBA) thymocytes (ALS) was injected intraperltoneally on days -4  and -2,  5  mg of cortisone acetate was injected in addition 
subcutaneously on  day -6,  or on  day --6  and day -2.  Mice did not  respond to  vaccinia virus with either protocol.  ALS-treatment alone 
reduced anti-vaccinia responses about 2-5-fold, and cortisone acetate treatment alone had no significant effect. 
were bled 10 d after the last boost. The result of the ALS plus cortisone treatment protocol was 
assessed by determining the numbers of spleen cells and the anti-vaccinia response of treated 
mice (Table I). Protocol 5  (cortison d-6, ALS d-4, ALS d-2)  was chosen and  in some cases 
repeated 2  mo  later. Four  independent  groups  of chimeras were  treated according to  this 
protocol. (b) Other chimeras were treated with cyclophosphamide (Endoxan-Asta Lot 9360, 
Asta-Werke AG,  D-4800  Bielefeld-14, (Federal Republic of Germany)  at  150  mg/kg.  Four 
independent groups of chimeras were treated according to this protocol. (c)  Some chimeras 
were irradiated a  second time with three doses of 300 rad in 2-d intervals. Three groups of 
chimeras were treated. (d) A  fourth group of F1 ~  P  chimeras was irradiated a  second time 
with a single dose of 850 rad and reconstituted again with T-cell depleted Fz bone marrow stem 
cells. Three groups of chimeras were treated. Chimeras treated with either of these additional 
protocols (a, b, c, d) were infected 3-5  mo later and  their lymphocytes tested for anti-viral 
cytotoxic T  cell activity. Chimeric lymphocytes were H-2  typed serologically and  by mixed 
lymphocyte culture (8). All chimeras studied were of Fa ~  P type. Further experimental details 
are given in the Tables. 
Virus Infection and 51Cr Release Assay.  About 107 plaque-forming units of WR vaccinia virus 
were injected intravenously into mice. 6 d later, mice were killed and spleen ceils tested for anti- 
vaccinia cytotoxic T  cell reactivity on  vaccinia-virus-infected or  -uninfected  L929  (H-2k), 
b  d  MC57G  (H-2), or D2  (H-2)  target cells, as described previously (8).  Experimental details 
(duration of test, spontaneous release, etc.) are given in the Tables. 
Results and Discussion 
These experiments were designed to look for evidence in  F1 ~  P 1 chimeras that 
antigen-presenting cells  of F1  origin  populate  the  thymus  and  function  to  select 
maturing Fa stem cells to express restriction specificity for P2.  Longo and  Schwartz 
(3)  have presented evidence and argued that  antigen-presenting cells of the thymus 
turn  over more slowly than  in spleens.  Early on,  therefore, stem  cells transfused to 
irradiated recipients will be exposed to the original recipient type antigen-presenting 
cells in the chimera. When antigen-presenting cells have turned  over in  the thymus 
(at least partially) during the 6-12 wk after irradiation and reconstitution, mature T 
cell pools are replenished; therefore, chances for new T  cells to differentiate and  be 
selected for donor-type restriction specificities are relatively slim. One has to deplete 
chimeras of mature T  cells that  had  been established  12-20 wk before to give stem 
cells a  good chance to be selected by immigrated donor-type antigen-presenting cells 1844  ROLF M. ZINKERNAGEL  BRIEF  DEFINITIVE REPORT 
in the thymus. Several protocols were used to deplete mature T  cells in chimeras at 
~3-4 mo after establishment of lymphohemopoietic chimerism. In Table II, experi- 
ments are  summarized  with  chimeras  treated with  cortisone plus  ALS  (Table II, 
experiment 819, 8159) or with Cytoxan (150 mg kg)  (Table II, experiment 810, 8159) 
or with three doses of 300 rad in 2-d intervals (Table II). In all examples shown, there 
was no significant change of the restriction specificity pattern of treated chimeras vs. 
control chimeras;  i.e.,  all  experimental  F1 ~  P1  animals  generated  virus-specific 
cytotoxic T  cells restricted to P1  but not to P2. This finding was symmetrical in F1 
P1  and  F1  ~  P2  chimeras  (experiment 8159).  Chimeras  were  all  H-2  typed 
serologically and some also by mixed lymphocyte culture; all were of F1 type. 
When chimeras were irradiated a second time with 850 rad and reconstituted again 
with T  cell-depleted F1 stem cells, their virus-specific effector T  cells tested  12 wk 
after the second treatment expressed only recipient type restriction specificity (ex- 
ample, Table III). These doubly irradiated chimeras possessed F1  lymphocytes by 
H-2 typing and by functional testing of effector  T cells after anti-H-2 plus C treatment 
(8). 
Combined, these data (from experiments using four different protocols) show that 
F~ stem cells maturing in 3-5-too-old established F1 ~  P  chimeras express recipient 
type restriction specificities predominantly. If there had been substantial numbers of 
antigen-presenting cells in the thymus derived from F~ stem cells that were able to 
select F1 stem cells during thymic maturation, all of the four protocols used should 
have allowed expression of both restriction specificities. 
The results obtained cannot be explained simply by arguing that Fa stem cells had 
been eliminated by  the  various  treatments,  resulting  in  regeneration  of host-type 
lymphocytes and restriction specificities. All of the chimeric lymphocytes were of F~ 
type, by serology and as determined by functional tests in several examples. 
The experimental approach, where established chimeras were treated again with a 
protocol similar to that used for the induction of original chimerism, is particularly 
useful for discussing the role of radioresistant antigen-presenting cells vs. radioresistant 
thymic  epithelial  cells  in  selection of restriction  specificities of cytotoxic T  cells. 
Whatever artifacts are invoked to explain the failure of the usual F~ ~  P1 chimeras 
to express restriction specificity for P2, they apply also to the second irradiation and 
reconstitution protocol. 
Our  results  differ from  those  published  by  Longo  and  Schartz  (7).  Using  the 
cortisone plus  ALS  protocol  to  reduce  the  mature  T  cell  pool,  they  found  that 
lymphocytes from F~ --o P1  chimeras expressed, with time, restriction specificity for 
P2.  At  least  two possible  (and  testable)  explanations for this  discrepancy come to 
mind. First, because Longo and Schwartz tested T  cell function and restriction in an 
antigen-specific proliferation assay, one may argue that induction and/or selection of 
restriction specificities of cytotoxic effector T  cells has other requirements than that of 
nonlytic,  differentiation-promoting T  cells  (helper,  delayed  type  hypersensitivity, 
proliferative T  cells).  Differential expression of H-2  antigens  might be compatible 
with this view, i.e., K  and D are expressed more strongly on thymic epithelial cells of 
the cortex and suhcortex, whereas Ia antigens are found in the medullary region and 
there predominantly on macrophagelike cells, as shown by Rouse and Weissman (9). 
Second, we  used  primary cytotoxic anti-viral  T  cell responses to  assess  restriction 
specificities, in contrast to the primed T  ceils used for antigen-specific proliferative T 
cell assays. There is no doubt that restriction is a quantitative phenomenon. Because T
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in primary anti-vaccinia experiments activity on infected recipient-type targets is at 
least  10-30 times greater than the (in most cases unmeasurable)  response on nonhost 
P2 targets, our results derive from the sensitive part of the titration curve. Titrations 
of proliferative  T  cell  activities  may  be  needed  to  assess  whether  there  are  no 
quantitative differences with respect to T  cells restricted to P1  vs. P2. 
Summary 
The proposal was tested that (P1 ×  P2) Fa --o P1 irradiation bone marrow chimeras 
expressed predominantly Pl-restricted T  cells because donor derived stem cells were 
exposed  to  recipient  derived  antigen-presenting  cells  in  the  thymus.  Because  P1 
recipient-derived  antigen-presenting  cells  are  replaced only slowly after  6-8  wk  by 
(P 1 ×  P2)  donor-derived antigen-presenting cells in the thymus and because replen- 
ished pools of mature T  cells may by then prevent substantial numbers of P2-restricted 
T  cells  to  be  generated,  a  large  portion  of thymus  cells  and  mature  T  cells  were 
eliminated  using  the  following  treatments  of  12-20-wk-old  (P1  ×  P2)  F1  ~  P1 
irradiation  bone  marrow  chimeras:  (a)  cortisone  plus  antilymphocyte  serum,  (b) 
Cytoxan,  (c)  three  doses of sublethal  irradiation  (300 rad)  2  d  apart,  and  (d)  lethal 
irradiation  (850 rad)  and reconstitution with T  cell-depleted (P1  ×  P2) F1 stem cells. 
12-20 wk after this second treatment,  (P1  ×  P2) ~  P1  chimeras were infected with 
vaccinia-virus. Virus-specific cytotoxic T  cell reactivity was expressed by chimeric T 
cells of (P1  ×  P2)  F1 origin and  was restricted  predominantly to P1.  Virus-specific 
cytotoxic T  cells,  therefore, do not seem to be selected to measurable extent  by the 
immigrating  donor-derived  antigen-presenting  cells  in  the  thymus;  their  selection 
depends apparently from the recipient-derived radioresistant  thymus cells. 
I thank A. Ahhage, R. Hermann, and S. Sutter for expert technical assistance, and M. Bucher 
for typing this manuscript. 
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